2013 ACBS Landline-Cellphone Combined Prevalence Tables

TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line And Cell Phone Combined Sample, United States, 2013

State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
California 238 46.4 4.9 (36.8 – 56.0) 255 48.6 4.8 (39.2 – 58.0)
Connecticut 252 60.5 4.9 (50.9 – 70.1) 274 53.2 5.6 (42.2 – 64.2)
Georgia 144 43.3 5.8 (31.9 – 54.7) 154 41.0 5.8 (29.6 – 52.4)
Hawaii 189 47.9 5.9 (36.3 – 59.5) 193 46.9 5.8 (35.5 – 58.3)
Indiana 406 55.4 3.6 (48.3 – 62.5) 429 53.7 3.5 (46.8 – 60.6)
Iowa 262 45.0 5.5 (34.2 – 55.8) 269 43.6 5.3 (33.2 – 54.0)
Maryland 264 49.3 5.3 (38.9 – 59.7) 285 46.8 5.1 (36.8 – 56.8)
Michigan 654 59.4 2.9 (53.7 – 65.1) 702 56.0 2.9 (50.3 – 61.7)
Mississippi 264 45.8 5.4 (35.2 – 56.4) 270 45.6 5.3 (35.2 – 56.0)
Missouri 274 56.9 5.4 (46.3 – 67.5) 284 54.8 5.3 (44.4 – 65.2)
Montana 320 56.7 4.4 (48.1 – 65.3) 348 50.3 4.9 (40.7 – 59.9)
Nebraska 324 41.2 5.8 (29.8 – 52.6) 350 39.6 5.4 (29.0 – 50.2)
Nevada 137 57.1 6.7 (44.0 – 70.2) 161 56.2 6.8 (42.9 – 69.5)
New Hampshire 266 50.9 5.2 (40.7 – 61.1) 281 47.8 5.0 (38.0 – 57.6)
New Jersey 313 40.6 4.2 (32.4 – 48.8) 349 36.8 3.9 (29.2 – 44.4)
New Mexico 324 54.7 4.2 (46.5 – 62.9) 343 52.0 4.4 (43.4 – 60.6)
New York 133 40.5 6.2 (28.3 – 52.7) 136 42.1 6.2 (29.9 – 54.3)
North Carolina 125 53.0 7.1 (39.1 – 66.9) 140 54.8 6.5 (42.1 – 67.5)
Ohio 318 52.9 5.3 (42.5 – 63.3) 335 50.6 5.0 (40.8 – 60.4)
Oklahoma 258 43.4 4.7 (34.2 – 52.6) 264 45.8 4.6 (36.8 – 54.8)
Oregon 199 59.4 5.4 (48.8 – 70.0) 221 56.4 5.3 (46.0 – 66.8)
Pennsylvania 313 51.4 4.1 (43.4 – 59.4) 342 50.1 3.8 (42.7 – 57.5)
Texas 265 56.0 6.0 (44.2 – 67.8) 295 51.5 5.6 (40.5 – 62.5)
Utah 441 54.9 3.4 (48.2 – 61.6) 460 53.5 3.4 (46.8 – 60.2)
Vermont 237 61.0 6.1 (49.0 – 73.0) 246 63.4 5.6 (52.4 – 74.4)
Washington 367 55.0 3.9 (47.4 – 62.6) 374 57.2 3.9 (49.6 – 64.8)
West Virginia 187 52.3 4.6 (43.3 – 61.3) 189 52.8 4.7 (43.6 – 62.0)
Wisconsin 265 55.0 5.7 (43.8 – 66.2) 265 56.4 5.7 (45.2 – 67.6)
Puerto Rico 334 40.9 4.1 (32.9 – 48.9) 402 36.9 3.6 (29.8 – 44.0)
28 state total 8,073 50.1 1.4 (47.4 – 52.8) 8,616 49.3 1.3 (46.8 – 51.8)
Median   52.9       50.6    
Range   40.5-61.0       36.8-63.4    

1 Aged ≥ 18 years

2 “Yes” response to “Do you still have asthma?”

3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Landline and cell phone combined sample size excludes “DK/Refused”

§ Standard error

Confidence interval